Inhibition of carbohydrate breakdown in brain by adrenergic beta-receptor blocking drugs: comparison of INPEA and propranolol.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D050260:Carbohydrate Metabolism; D005260:Female; D006003:Glycogen / Q000378:metabolism; D006600:Hexosephosphates / Q000378:metabolism; D007773:Lactates / Q000378:metabolism; D008297:Male; D051379:Mice; D011433:Propranolol / Q000494:pharmacology*; D011773:Pyruvates / Q000378:metabolism; D013565:Sympatholytics / Q000494:pharmacology*
D000319:Adrenergic beta-Antagonists; D006600:Hexosephosphates; D007773:Lactates; D011773:Pyruvates; D013565:Sympatholytics; D006003:Glycogen; D011433:Propranolol